Resphera biosciences, LLC:1242305 [19-014163]
Ended Purchase Order Awarded Last action
- Contract number
- 75N91019P00133
- Awardee
-
Resphera Biosciences LLC UEI KN8XS8DJHMF1
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $24,000
Award facts
- Contract value 100% obligated
- $24,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541690 Other Scientific and Technical Consulting Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute awarded a purchase order to Resphera Biosciences LLC for $24,000 on January 28, 2019, with a completion date of June 29, 2019. Work is performed in Bethesda, Maryland. The order carries firm fixed pricing and uses no small business set-aside.
Quick answers
Who was awarded contract 75N91019P00133?
75N91019P00133 was awarded to Resphera Biosciences LLC by National Cancer Institute (National Institutes of Health) on January 28, 2019.
How much is contract 75N91019P00133 worth?
The government has obligated $24,000 on 75N91019P00133.
Was contract 75N91019P00133 competed?
The extent of competition for 75N91019P00133 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award